Trial intelligence / Profile preview

INCB013739 in Obese Type 2 Diabetes

NCT00478322Phase 2Completed

Sponsor
Incyte
Start
Apr 2007
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of INCB013739 in type 2 diabetes mellitus (T2DM), sponsored by Incyte. Started Apr 2007; status: completed.

02

Drugs

INCB013739
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00478322.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00478322.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call